ALRN Aileron Therapeutics Inc

0.00 (0.0%)
Pre Market
Last Updated: 04:17:06
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 0
Bid Price 0.9368
Ask Price 1.79
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Aileron Therapeutics Inc ALRN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.52 04:17:06
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 1.12 - 5.64
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.52 USD

Aileron Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.9M 4.54M - 0 -27.33M -6.02 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Aileron Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ALRN Message Board. Create One! See More Posts on ALRN Message Board See More Message Board Posts

Historical ALRN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.521.591.41771.509,3070.000.0%
1 Month1.681.761.41771.5611,478-0.16-9.52%
3 Months1.942.09021.41771.7116,496-0.42-21.65%
6 Months1.292.13491.121.6420,9710.2317.83%
1 Year4.205.641.123.3886,899-2.68-63.81%
3 Years25.2049.401.1224.56783,560-23.68-93.97%
5 Years55.8061.981.1223.55641,583-54.28-97.28%

Aileron Therapeutics Description

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects.